Today: 2 July 2026
Browse Category

NASDAQ:TGT 23 October 2025

Target Stock Crash: Shares Dive to Multi-Year Lows Amid CEO Shakeup and Retail Woes

Target Stock Crash: Shares Dive to Multi-Year Lows Amid CEO Shakeup and Retail Woes

As of mid‑October 2025, Target’s stock remains under heavy pressure. At the close on Oct. 22, 2025, TGT was about $94stockinvest.us, with the stock hovering just above its 52-week low. TradingView reports TGT at $94.25 USD on Oct. 23, up ~0.2% on the daytradingview.com, but still far below last year’s highs. This leaves TGT down roughly 35% for 2025nasdaq.com. By comparison, Walmart’s stock has climbed about +18% year‑to‑datenasdaq.com and Costco’s about +3%reuters.com, underscoring Target’s relative weakness. Target’s forward P/E is near 12–13x, well below historical norms and peersinvesting.comreuters.com. The high dividend yield reflects this depressed pricenasdaq.comreuters.com. Market sentiment is cautious: as one ts2.tech roundup notes, TGT is “near multi-year lows”ts2.tech. Wall Street opinions on Target are mixed but generally cautious. Morgan Stanley reiterated an Overweight rating with a $160 price targetinvesting.com, arguing TGT is “undervalued” at ~10.5x forward earnings vs. peers at ~36xinvesting.com. MS analysts see a potential pick‑up if macro pressures ease. In contrast, Guggenheim cut its 12-month target from $155 to $115 but kept a Buy callinvesting.com. Guggenheim noted Target’s shrinking comps and broader 2025 guidance range but still forecasts 15–20% upside from current pricesinvesting.com.
23 October 2025

Stock Market Today

  • IperionX (ASX:IPX) Gets Up to US$6.6M Defense Grant for Titanium Output
    July 1, 2026, 7:47 PM EDT. IperionX Limited (ASX:IPX) landed as much as US$6.6 million from a U.S. Department of Defense program to boost titanium plate and parts production at its Virginia site. The funding stacks on top of previous prototype and purchase deals. IperionX is still pre-revenue and has logged net losses over US$30 million, with investors keeping an eye on the company's execution risks. Shares are valued between A$8.87 and A$10.51, as the market weighs the company's hefty spend and ongoing losses. The contract could validate IperionX's titanium process and scale, though investors remain cautious about future performance.
Go toTop